Titanium mesh covered with biocompatible polypropylene film for covering and protecting bone grafts/biomaterials and process for obtaining same
US-2024398571-A1 · Dec 5, 2024 · US
US10864296B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10864296-B2 |
| Application number | US-201715646684-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jul 11, 2017 |
| Priority date | May 2, 2016 |
| Publication date | Dec 15, 2020 |
| Grant date | Dec 15, 2020 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A polyelectrolyte coating comprises at least one polycationic layer consisting of at least one polyarginine as herein defined and at least one polyanionic layer consisting of hyaluronic acid. The polyelectrolyte coating has a biocidal activity and the invention thus further refers to the use of said polyelectrolyte coating for producing a device, in particular a bacteriostatic medical device, more particularly an implantable device, comprising said polyelectrolyte coating, and a method for preparing said device and a kit. Also disclosed is a method of preventing a bacterial infection in an individual.
Opening claim text (preview).
The invention claimed is: 1. A polyelectrolyte coating having biocidal activity, comprising: (a) at least one polycationic layer consisting of at least one polyarginine consisting of n repetitive arginine units, wherein n is an integer comprised between 2 and 10 and wherein the individual polyarginine chains are mobile and/or diffuse within the polyelectrolyte coating, and (b) at least one polyanionic layer consisting of hyaluronic acid; wherein the polyelectrolyte coating comprises 40 to 200 polycationic layers and 40 to 200 polyanionic layers. 2. The polyelectrolyte coating according to claim 1 , wherein said polyelectrolyte coating comprises 48 to 200 polycationic layers. 3. The polyelectrolyte coating according to claim 1 , wherein said polyelectrolyte coating comprises 48 to 200 polyanionic layers. 4. The polyelectrolyte coating according to claim 1 , wherein the number of the polycationic layers and the number of the polyanionic layers are the same or differ by one layer. 5. The polyelectrolyte coating according to claim 1 , wherein said coating further comprises a pharmaceutical active drug. 6. The polyelectrolyte coating according to claim 1 , wherein said coating is biocompatible. 7. A device comprising a polyelectrolyte coating having biocidal activity, wherein said polyelectrolyte coating comprises: (a) at least one polycationic layer consisting of at least one polyarginine consisting of n repetitive arginine units, wherein n is an integer comprised between 2 and 10 and wherein the individual polyarginine chains are mobile and/or diffuse within the polyelectrolyte coating, and (b) at least one polyanionic layer consisting of hyaluronic acid; wherein the polyelectrolyte coating comprises 40 to 200 polycationic layers and 40 to 200 polyanionic layers. 8. The device of claim 7 , wherein the polyelectrolyte coating covers at least a portion of the surface of said device. 9. The device of claim 7 , wherein said device is a medical device. 10. The device of claim 9 , wherein said device is an implantable device. 11. The implantable device according to claim 10 , wherein the implantable device is selected from the group comprising catheters, arteriovenous shunts, breast implants, cardiac and other monitors, cochlear implants, defibrillators, dental implants, maxillofacial implants, middle ear implants, neurostimulators, orthopedic devices, pacemaker and leads, penile implants, prosthetic devices, replacement joints, spinal implants, voice prosthesis, artificial hearts, contact lenses, fracture fixation device, infusion pumps, intracranial pressure device, intraocular lenses, intrauterine devices, joint prosthesis, mechanical heart valves, orthopedic devices, suture materials, urinary stents, vascular assist device, vascular grafts, vascular shunts and vascular stents, and artificial vessels of permanent or transient types. 12. A method for preparing a device comprising a polyelectrolyte coating having biocidal activity, the method comprising: (a) providing a device; (b1) depositing on the surface of said device (i) at least one polycationic layer consisting of at least one polyarginine consisting of n repetitive arginine units, wherein n is an integer comprised between 2 and 10, and then ii) at least one polyanionic layer consisting of hyaluronic acid, or (b2) depositing on the surface of said device ii) and then i) as defined above, and repeating b1) and/or b2) so that the polyelectrolyte coating comprises 40 to 200 polycationic layers and 40 to 200 polyanionic layers. 13. The method for preparing a device according to claim 12 , further comprising at least one washing after i) and/or ii) of b1) or b2). 14. The method for preparing a device according to claim 13 , further comprising at least one drying after i) and/or ii) of b1) or b2) and/or the at least one washing. 15. A method of preventing a bacterial infection in an individual undergoing an implantation of an implantable device comprising: i) providing an implantable device comprising a polyelectrolyte coating having biocidal activity, wherein said polyelectrolyte coating comprises: (a) at least one polycationic layer consisting of at least one polyarginine consisting of n repetitive arginine units, wherein n is an integer comprised between 2 and 10 and wherein the individual polyarginine chains are mobile and/or diffuse within the polyelectrolyte coating, and (b) at least one polyanionic layer consisting of hyaluronic acid, wherein the polyelectrolyte coating comprises 40 to 200 polycationic layers and 40 to 200 polyanionic layers, and ii) implanting said implantable device in the individual, wherein said implantable device prevents a bacterial infection. 16. The method of claim 15 , wherein the bacterial infection is a nosocomial infection. 17. The polyelectrolyte coating according to claim 1 , wherein said polyelectrolyte coating comprises 48 to 200 polycationic layers and 48 to 200 polyamomc layers. 18. The device of claim 7 , wherein said device is a bandage.
Macromolecular materials · CPC title
Macromolecular materials · CPC title
Alpha-amino-carboxylic acids {(polysuccinimides C08G73/1092)} · CPC title
Amino acids · CPC title
Polyamides derived from alpha-amino carboxylic acids (C08L77/10 takes precedence) · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.